Multicenter, double-blind randomized, controlled study for the treatment of involutional osteoporosis
Phase 3
- Conditions
- Involutional osteoporosis
- Registration Number
- JPRN-jRCT2080220085
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Patients of female aged 45 years or older with documented involutional osteoporosis according to the diagnostic criteria for primaly osteoporosis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method